Human PAH is characterized by a pattern of lipid-related insulin resistance

作者: Anna R. Hemnes , J. Matthew Luther , Christopher J. Rhodes , Jason P. Burgess , James Carlson

DOI: 10.1172/JCI.INSIGHT.123611

关键词:

摘要: BACKGROUND. Pulmonary arterial hypertension (PAH) is a deadly disease of the small pulmonary vasculature with an increased prevalence insulin resistance (IR). Insulin regulates both glucose and lipid homeostasis. We sought to quantify glucose- lipid-related IR in human PAH, testing hypothesis that lipoprotein indices are more sensitive PAH. METHODS. Oral tolerance PAH patients triglyceride-matched (TG-matched) controls proteomic, metabolomics, analyses were performed controls. Results validated external cohort explanted lungs. RESULTS. similarly intolerant or by homeostasis metrics compared control when matched for metabolic syndrome. Using insulin-sensitive index, TG/HDL ratio, commonly than Proteomic metabolomic analysis demonstrated separation between controls, driven differences species. observed significant increase long-chain acylcarnitines, phosphatidylcholines, metabolism–related proteins, oxidized LDL receptor 1 (OLR1) plasma discovery validation cohort. had higher axis–related lipoprotein-based inflammation scores patient lung tissue showed enhanced OLR1 immunostaining within plexiform lesions accumulation macrophages. CONCLUSIONS. characterized alterations axes, manifest elevated circulating medium- acylcarnitines lipoproteins. Oxidized its may play role proinflammatory phenotype PAH. FUNDING. NIH {"type":"entrez-nucleotide","attrs":{"text":"DK096994","term_id":"187460004"}}DK096994, {"type":"entrez-nucleotide","attrs":{"text":"HL060906","term_id":"1051598402"}}HL060906, UL1 RR024975-01, TR000445-06, {"type":"entrez-nucleotide","attrs":{"text":"DK020593","term_id":"187398843"}}DK020593, P01 HL108800-01A1, TR002243; American Heart Association 13FTF16070002.

参考文章(50)
Franklin H. Epstein, Daniel Steinberg, Sampath Parthasarathy, Thomas E. Carew, John C. Khoo, Joseph L. Witztum, Beyond Cholesterol New England Journal of Medicine. ,vol. 320, pp. 915- 924 ,(1989) , 10.1056/NEJM198904063201407
Brian B. Graham, Rahul Kumar, Claudia Mickael, Linda Sanders, Liya Gebreab, Kendra M. Huber, Mario Perez, Peter Smith-Jones, Natalie J. Serkova, Rubin M. Tuder, Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake American Journal of Physiology-lung Cellular and Molecular Physiology. ,vol. 309, ,(2015) , 10.1152/AJPLUNG.00169.2015
Cosimo Giannini, Nicola Santoro, Sonia Caprio, Grace Kim, Derek Lartaud, Melissa Shaw, Bridget Pierpont, Ram Weiss, The Triglyceride-to-HDL Cholesterol Ratio: Association with insulin resistance in obese youths of different ethnic backgrounds Diabetes Care. ,vol. 34, pp. 1869- 1874 ,(2011) , 10.2337/DC10-2234
Joshua P. Fessel, Rizwan Hamid, Bryan M. Wittmann, Linda J. Robinson, Tom Blackwell, Yuji Tada, Nobuhiro Tanabe, Koichiro Tatsumi, Anna R. Hemnes, James D. West, Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming. Pulmonary circulation. ,vol. 2, pp. 201- 213 ,(2012) , 10.4103/2045-8932.97606
Meredith E. Pugh, Ivan M. Robbins, Todd W. Rice, James West, John H. Newman, Anna R. Hemnes, Unrecognized glucose intolerance is common in pulmonary arterial hypertension Journal of Heart and Lung Transplantation. ,vol. 30, pp. 904- 911 ,(2011) , 10.1016/J.HEALUN.2011.02.016
Steven M. Kawut, Emilia Bagiella, David J. Lederer, Daichi Shimbo, Evelyn M. Horn, Kari E. Roberts, Nicholas S. Hill, R. Graham Barr, Erika B. Rosenzweig, Wendy Post, Russell P. Tracy, Harold I. Palevsky, Paul M. Hassoun, Reda E. Girgis, Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension ASA-STAT Circulation. ,vol. 123, pp. 2985- 2993 ,(2011) , 10.1161/CIRCULATIONAHA.110.015693
Tracey McLaughlin, Fahim Abbasi, Karen Cheal, James Chu, Cindy Lamendola, Gerald Reaven, Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine. ,vol. 139, pp. 802- 809 ,(2003) , 10.7326/0003-4819-139-10-200311180-00007
Levi Benson, Evan L. Brittain, Meredith E. Pugh, Eric D. Austin, Kelly Fox, Lisa Wheeler, Ivan M. Robbins, Anna R. Hemnes, Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension. Pulmonary circulation. ,vol. 4, pp. 311- 318 ,(2014) , 10.1086/675994
Alexis C Frazier-Wood, Timothy W Garvey, Tara Dall, Robert Honigberg, Ray Pourfarzib, None, Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction. Metabolic Syndrome and Related Disorders. ,vol. 10, pp. 244- 251 ,(2012) , 10.1089/MET.2011.0148
Elias J. Jeyarajah, William C. Cromwell, James D. Otvos, Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clinics in Laboratory Medicine. ,vol. 26, pp. 847- 870 ,(2006) , 10.1016/J.CLL.2006.07.006